Top Clinical Trials companies in Italy by Capital Expenditure

This ranking features the top 2 Clinical Trials companies in Italy ranked by Capital Expenditure, totaling a Capital Expenditure of USD -6.13 M, for February 06, 2025.

Italy

Clinical Trials
Capital Expenditure
#
Name
Capital Expenditure
 Reported Date
Stock Price
Change
 Price (30 days) Country
1
PHIL.MI

Philogen S.p.A.

1

PHIL.MI
USD -6.12 M
Dec. 31, 2023 USD 19.14 -0.29%

Italy
2
NP5.DE

Newron Pharmaceuticals S.p.A.

2

NP5.DE
USD -12.14 K
Dec. 31, 2023 USD 10.86 4.76%

Italy
Frequently Asked Questions
  • Which Clinical Trials company in Italy has the highest Capital Expenditure ?

    The Clinical Trials company in Italy with the highest Capital Expenditure is Philogen S.p.A. (Milan Stock Exchange: PHIL.MI) at USD -6.12 M.

  • Which Clinical Trials company in Italy has the lowest Capital Expenditure ?

    The Clinical Trials company in Italy with the lowest Capital Expenditure is Newron Pharmaceuticals S.p.A. (XETRA: NP5.DE) at USD -12.14 K.

SV Wall Street